KIYATEC Announces Investment from Seae Ventures and Names Co-founder and Managing Partner Jason Robart to its Board of Directors
01 May, 2021
– Glytec announced $21m in financing from SVB, Savitr Capital and other private investors.
– The funding will fuel Glytec’s mission of revolutionizing the role glycemic management plays in the hospital across every department.
– The combined $9m debt financing from SVB and $12m equity investment led by Savitr positions the company to continue its rapid growth by investing in research and development around patient safety, provider workflows and analytics, adding additional talent to its workforce and enhancing integrations with EHRs, mobile apps and other diabetes technology across the continuum of care.
– More than 34m Americans today live with diabetes, 88m live with prediabetes and over one-third of all patients – regardless of a diabetes diagnosis – require insulin during their hospital stay.